Traditional treatments often involve invasive surgeries or long-term medication use, which can come with their own set of complications and side effects
doi:10.1016/S0140-6736(23)01053-X PubMed: This trial evaluated retatrutide in 281 participants with type 2 diabetes, showing up to 16.94% weight loss and significant HbA1c reductions with favorable safety profile comparable to other GLP-1 based therapies
Therefore, clearing senescent cells is crucial for delaying the aging process (Su et al., 2021)
This dual-peptide blend combines two research bioactive sequences: BPC-157, a gastric-derived synthetic peptide fragment, and TB-500 (Thymosin Beta-4 fragment), a stabilized actin-binding regulator analogue
Asghar, F., Shamim, N., Farooque, U., Sheikh, H., & Aqeel, R